These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2049047)

  • 1. A mouse model for Borrelia burgdorferi infection: pathogenesis, immune response and protection.
    Schaible UE; Wallich R; Kramer MD; Museteanu C; Simon MM
    Behring Inst Mitt; 1991 Feb; (88):59-67. PubMed ID: 2049047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice.
    Schaible UE; Kramer MD; Eichmann K; Modolell M; Museteanu C; Simon MM
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3768-72. PubMed ID: 2339119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis.
    Schaible UE; Kramer MD; Wallich R; Tran T; Simon MM
    Eur J Immunol; 1991 Oct; 21(10):2397-405. PubMed ID: 1915553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-mediated resolution of Lyme arthritis in mice.
    Barthold SW; deSouza M; Feng S
    Lab Invest; 1996 Jan; 74(1):57-67. PubMed ID: 8569198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.
    Krause A; Burmester GR; Rensing A; Schoerner C; Schaible UE; Simon MM; Herzer P; Kramer MD; Wallich R
    J Clin Invest; 1992 Sep; 90(3):1077-84. PubMed ID: 1522216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver.
    Schaible UE; Gay S; Museteanu C; Kramer MD; Zimmer G; Eichmann K; Museteanu U; Simon MM
    Am J Pathol; 1990 Oct; 137(4):811-20. PubMed ID: 2221014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone.
    Schaible UE; Wallich R; Kramer MD; Nerz G; Stehle T; Museteanu C; Simon MM
    Int Immunol; 1994 May; 6(5):671-81. PubMed ID: 8080839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant vaccine for Lyme disease.
    Wallich R; Kramer MD; Simon MM
    Behring Inst Mitt; 1994 Dec; (95):106-8. PubMed ID: 7755503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
    Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease.
    Simon MM; Schaible UE; Wallich R; Kramer MD
    Immunol Today; 1991 Jan; 12(1):11-6. PubMed ID: 2015043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial-infection protocols allow immunodetection of novel Borrelia burgdorferi antigens suitable as vaccine candidates against Lyme disease.
    Wallich R; Jahraus O; Stehle T; Tran TT; Brenner C; Hofmann H; Gern L; Simon MM
    Eur J Immunol; 2003 Mar; 33(3):708-19. PubMed ID: 12616491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice.
    Simon MM; Schaible UE; Kramer MD; Eckerskorn C; Museteanu C; Müller-Hermelink HK; Wallich R
    J Infect Dis; 1991 Jul; 164(1):123-32. PubMed ID: 1829104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen.
    Schaible UE; Gern L; Wallich R; Kramer MD; Prester M; Simon MM
    Immunol Lett; 1993 May; 36(2):219-26. PubMed ID: 8349316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective antibodies in murine Lyme disease arise independently of CD40 ligand.
    Fikrig E; Barthold SW; Chen M; Grewal IS; Craft J; Flavell RA
    J Immunol; 1996 Jul; 157(1):1-3. PubMed ID: 8683101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula.
    Nassal M; Skamel C; Kratz PA; Wallich R; Stehle T; Simon MM
    Eur J Immunol; 2005 Feb; 35(2):655-65. PubMed ID: 15668917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective antibodies develop, and murine Lyme arthritis regresses, in the absence of MHC class II and CD4+ T cells.
    Fikrig E; Barthold SW; Chen M; Chang CH; Flavell RA
    J Immunol; 1997 Dec; 159(11):5682-6. PubMed ID: 9548512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice.
    Bockenstedt LK; Fikrig E; Barthold SW; Flavell RA; Kantor FS
    J Immunol; 1996 Dec; 157(12):5496-502. PubMed ID: 8955199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
    Schaible UE; Wallich R; Kramer MD; Gern L; Anderson JF; Museteanu C; Simon MM
    Vaccine; 1993; 11(10):1049-54. PubMed ID: 8212826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice.
    Keane-Myers A; Maliszewski CR; Finkelman FD; Nickell SP
    J Immunol; 1996 Apr; 156(7):2488-94. PubMed ID: 8786309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines.
    Nassal M; Skamel C; Vogel M; Kratz PA; Stehle T; Wallich R; Simon MM
    Int J Med Microbiol; 2008 Jan; 298(1-2):135-42. PubMed ID: 17888729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.